Tag:
Talabostat
Latest Headlines
Latest Headlines
Dara BioSciences goes public in reverse merger
Dara BioSciences has completed a reverse merger with the nearly-defunct Point Therapeutics ,
Talabostat trials put on hold on discouraging data
Regulators have dealt another blow to Point Therapeutics, putting their late-stage trials of the lung cancer therapy talabostat on clinical hold based on interim results. The company announced that
SPOTLIGHT: Talabostat heads to Phase III
Point Therapeutics says it will push Talabostat for pancreatic
